July 6, 2025 - 04:15

In a significant advancement for the drone industry, STM GM has unveiled major breakthroughs in GPS-free unmanned aerial vehicle (UAV) systems and swarm technology. The completion of the KERKES project marks a pivotal moment in the development of autonomous drone operations that do not rely on GPS signals. This innovation addresses one of the key limitations faced by drone technology, particularly in environments where GPS is unavailable or unreliable.
The KERKES project has successfully demonstrated the capability of drone swarms to navigate and operate effectively without GPS, paving the way for enhanced applications in various sectors, including agriculture, search and rescue, and environmental monitoring. Additionally, accelerated testing of first-person view (FPV) drones has yielded promising results, showcasing improved navigation and coordination among multiple drones operating simultaneously.
These advancements not only enhance the functionality of drone swarms but also open new avenues for their use in complex and dynamic environments, marking a significant step forward in the evolution of UAV technology.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...